Showing results (301-310 of 398) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trialJeeyun Lee, Do Hoon Lim, Sung Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancerJinny Park, Byung Bae Park, Jee Youn Kim, et al.The Lancet. Oncology|August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion studyMartin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.Oncotarget|December 2, 2016
The implication of FLT3 amplification for FLT targeted therapeutics in solid tumorsSung Hee Lim, Sun-Young Kim, Kyung Kim, et al.International Journal of Cancer|December 31, 2024
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trialViktor Grünwald, Rana R McKay, Tomas Buchler, et al.Oncology Reports|March 23, 2011
Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic targetJeeyun Lee, Jin Won Seo, Hyun Jung Jun, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2020
Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer: Analysis of the ARTIST phase III trialJeong Il Yu, Changhoon Choi, Jeeyun Lee, et al.Journal of Korean Medical Science|October 29, 2008
Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemiaSoo-Mee Bang, Jeong Yeal Ahn, Jiyoon Park, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset AnalysesSe Hoon Park, Tae Sung Sohn, Jeeyun Lee, et al.Cancer Research and Treatment|June 10, 2022
A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal CancerHyunji Jo, Seung Tae Kim, Jeeyun Lee, et al.Pageof 40